Notice of Closed Meeting, 460 [2021-28523]
Download as PDF
<![CDATA[
TKELLEY on DSK125TN23PROD with NOTICE
460
Federal Register / Vol. 87, No. 3 / Wednesday, January 5, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Notice of Closed Meeting
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—RFA–CE–22–002,
Grants to Support New Investigators in
Conducting Research Related to Preventing
Interpersonal Violence Impacting Children
and Youth.
Dates: March 8–9, 2022.
Times: 8:30 a.m.–5:30 p.m., EST.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Aisha L.
Wilkes, M.P.H., Scientific Review Officer,
National Center for Injury Prevention and
Control, CDC, 4770 Buford Highway NE,
Mailstop S106–9, Atlanta, Georgia 30341–
3717, Telephone: (404) 639–6473, Email:
AWilkes@cdc.gov.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—RFA–CE–22–001,
Grants to Support New Investigators in
Conducting Research Related to
Understanding Polydrug Use Risk and
Protective Factors.
Dates: March 15–16, 2022.
Times: 8:30 a.m.–5:30 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Aisha L.
Wilkes, M.P.H., Scientific Review Officer,
National Center for Injury Prevention and
Control, CDC, 4770 Buford Highway NE,
Mailstop S106–9, Atlanta, Georgia 30341–
3717, Telephone: (404) 639–6473, Email:
AWilkes@cdc.gov.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—Funding Opportunity
Announcement (FOA), PAR 20–280,
Cooperative Research Agreements Related to
the World Trade Center Health Program
(U01); and RFA OH–22–004, World Trade
Center Health Research related to WTC
Survivors (U01—No Applications with
Responders Accepted).
Dates: March 22–23, 2022.
Times: 11:00 a.m.–5:00 p.m., EDT.
Place: Virtual.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Laurel
Garrison, M.P.H., Scientific Review Officer,
National Institute for Occupational Safety
and Health, CDC, 5555 Ridge Avenue,
Cincinnati, Ohio 45213, Telephone: (513)
533–8324, Email: LGarrison@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–28522 Filed 1–4–22; 8:45 am]
[FR Doc. 2021–28523 Filed 1–4–22; 8:45 am]
[FR Doc. 2021–28524 Filed 1–4–22; 8:45 am]
BILLING CODE P
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
VerDate Sep<11>2014
18:05 Jan 04, 2022
Jkt 256001
PO 00000
Frm 00037
Fmt 4703
Sfmt 9990
E:\FR\FM\05JAN1.SGM
05JAN1
]]>Agencies
[Federal Register Volume 87, Number 3 (Wednesday, January 5, 2022)]
[Notices]
[Page 460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28523]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--RFA-CE-22-001, Grants to
Support New Investigators in Conducting Research Related to
Understanding Polydrug Use Risk and Protective Factors.
Dates: March 15-16, 2022.
Times: 8:30 a.m.-5:30 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Aisha L. Wilkes, M.P.H.,
Scientific Review Officer, National Center for Injury Prevention and
Control, CDC, 4770 Buford Highway NE, Mailstop S106-9, Atlanta,
Georgia 30341-3717, Telephone: (404) 639-6473, Email:
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-28523 Filed 1-4-22; 8:45 am]
BILLING CODE 4163-18-P
